5,140 Shares in Astera Labs, Inc. $ALAB Bought by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 5,140 shares of the company’s stock, valued at approximately $1,006,000.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Clearstead Advisors LLC boosted its holdings in shares of Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after acquiring an additional 76 shares during the period. Great Valley Advisor Group Inc. increased its holdings in shares of Astera Labs by 2.2% in the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after acquiring an additional 90 shares during the period. Rye Brook Capital LLC lifted its position in Astera Labs by 1.1% in the 3rd quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock valued at $1,801,000 after purchasing an additional 100 shares during the last quarter. Assetmark Inc. lifted its position in Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares during the last quarter. Finally, SlateStone Wealth LLC boosted its stake in Astera Labs by 1.3% during the 3rd quarter. SlateStone Wealth LLC now owns 12,744 shares of the company’s stock valued at $2,495,000 after purchasing an additional 160 shares during the period. 60.47% of the stock is currently owned by institutional investors.

Insider Activity

In other Astera Labs news, Director Jack R. Lazar sold 7,500 shares of the company’s stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $119.80, for a total value of $898,500.00. Following the completion of the sale, the director directly owned 87,351 shares in the company, valued at $10,464,649.80. This represents a 7.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Sanjay Gajendra sold 94,971 shares of the stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51. Following the transaction, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 224,292 shares of company stock valued at $27,676,069 over the last 90 days. Corporate insiders own 12.50% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Royal Bank Of Canada initiated coverage on shares of Astera Labs in a research report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 target price for the company. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Citigroup reduced their price objective on Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, February 11th. Loop Capital initiated coverage on Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective for the company. Finally, Raymond James Financial began coverage on Astera Labs in a research report on Friday, November 21st. They issued a “hold” rating on the stock. Fifteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $195.89.

Astera Labs Trading Down 3.9%

Astera Labs stock opened at $119.90 on Friday. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90. The stock has a market cap of $20.41 billion, a price-to-earnings ratio of 98.28, a PEG ratio of 2.45 and a beta of 1.74. The company’s 50-day moving average price is $149.08 and its two-hundred day moving average price is $168.55.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The company had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The business’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.